Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Wes, Paul D ^a   Easton, Amy ^a   Corradi, John ^a   Barten, Donna M ^a   Devidze, Nino ^a   DeCarr, Lynn B ^a   Truong, Amy ^a   He, Aiqing ^a   Barrezueta, Nestor X ^a   Polson, Craig ^a   Bourin, Clotilde ^a   Flynn, Marianne E ^a   Keenan, Stefanie ^a   Lidge, Regina ^a   Meredith, Jere ^a   Natale, Joanne ^a   Sankaranarayanan, Sethu ^a   Cadelina, Greg W ^a   Albright, Charlie F ^a   Cacace, Angela M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

AGE; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CENTRAL NERVOUS SYSTEM FUNCTION; CHROMOSOME 17; CONTROLLED STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; GENOTYPE; HIPPOCAMPUS; IMMUNE RESPONSE; LASER MICRODISSECTION; MICROGLIA; MOUSE; MOUSE MODEL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PATHOPHYSIOLOGY; RECOGNITION; SHORT TERM MEMORY; SPATIAL MEMORY; TRANSGENE; WORKING MEMORY; ANIMAL; DEGENERATIVE DISEASE; DISEASE MODEL; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETICS; HUMAN; INFLAMMATION; METABOLISM; NERVE CELL;

ALZHEIMER DISEASE; ANIMALS; CHROMOSOMES, HUMAN, PAIR 17; DISEASE MODELS, ANIMAL; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENE REGULATORY NETWORKS; HIPPOCAMPUS; HUMANS; INFLAMMATION; MICE; MICROGLIA; MICROTUBULE-ASSOCIATED PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; PARKINSONIAN DISORDERS; TAU PROTEINS;

EID: 84934756346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106050     Document Type: Article

References (63)

1. Lee VMY, Goedert M, Trojanowski JQ (2001) Neurodegenerative Tauopathies. Annual Review of Neuroscience 24: 1121-1159. (Pubitemid 32695256)
2. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, et al. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol 41: 706-715. (Pubitemid 27249175)
3. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, et al. (1998) Association of missense and 5 [prime]-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705.
4. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, et al. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43: 815-825. (Pubitemid 28280226)
5. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, et al. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences 95: 7737-7741. (Pubitemid 28293323)
6. Forman MS, Trojanowski JQ, Lee VMY (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10: 1055-1063. (Pubitemid 39424865)
7. Morris M, Maeda S, Vossel K, Mucke L (2011) The Many Faces of Tau. Neuron 70: 410-426.
8. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, et al. (2010) Dendritic Function of Tau Mediates Amyloid-b Toxicity in Alzheimer's Disease Mouse Models. Cell 142: 387-397.
9. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, et al. (2011) Amyloid-/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease. Journal of Neuroscience 31: 700-711.
10. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, et al. (2007) Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model. Science 316: 750-754. (Pubitemid 46717684)
11. Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
12. Miller JA, Woltjer RL, Goodenbour JM, Horvath S, Geschwind DH (2013) Genes and pathways underlying regional and cell type changes in Alzheimer's disease. Genome Med 5: 48.
13. Gandy S, Heppner FL (2013) Microglia as dynamic and essential components of the amyloid hypothesis. Neuron 78: 575-577.
14. Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, et al. (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153: 707-720.
15. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45: 1452-1458.
16. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, et al. (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368: 107-116.
17. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, et al. (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117-127.
18. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435.
19. Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, et al. (2013) CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci 33: 13320-13325.
20. Myers AJ (2013) AD gene 3-D: moving past single layer genetic information to map novel loci involved in Alzheimer's disease. J Alzheimers Dis 33 Suppl 1: S15-22.
21. Lee VMY, Kenyon TK, Trojanowski JQ (2005) Transgenic animal models of tauopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1739: 251-259. (Pubitemid 40018542)
22. SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, et al. (2005) Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function. Science 309: 476-481. (Pubitemid 40994688)
23. Barten DM, Cadelina GW, Hoque N, DeCarr LB, Guss VL, et al. (2011) Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers. Journal of Alzheimer's Disease 24: 127-141.
24. Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, et al. (2005) Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L). The Journal of Neuroscience 25: 10637-10647. (Pubitemid 41681911)
25. Spires TL, Orne JD, SantaCruz K, Pitstick R, Carlson GA, et al. (2006) Region-specific Dissociation of Neuronal Loss and Neurofibrillary Pathology in a Mouse Model of Tauopathy. The American Journal of Pathology 168: 1598-1607.
26. Yue M, Hanna A, Wilson J, Roder H, Janus C (2011) Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy. Neurobiology of Aging 32: 590-603.
27. Crimins JL, Rocher AB, Peters A, Shultz P, Lewis J, et al. (2011) Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy. Acta Neuropathol 122: 551-564.
28. Nash KR, Lee DC, Hunt JB Jr., Morganti JM, Selenica ML, et al. (2013) Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Neurobiol Aging 34: 1540-1548.
29. Kopeikina KJ, Polydoro M, Tai HC, Yaeger E, Carlson GA, et al. (2013) Synaptic alterations in the rTg4510 mouse model of tauopathy. J Comp Neurol 521: 1334-1353.
30. Bailey RM, Howard J, Knight J, Sahara N, Dickson DW, et al. (2014) Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Mol Neurodegener 9: 8.
31. Sahara N, DeTure M, Ren Y, Ebrahim AS, Kang D, et al. (2013) Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. J Alzheimers Dis 33: 249-263.
32. Eisenhart C (1947) The assumptions underlying the analysis of variance. Biometrics 3: 1-21.
33. Dunlop DD, Tamhane AC (2000) Statistics and data analysis: from elementary to intermediate: Prentice Hall.
34. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological): 289-300.
35. Lalonde R (2002) The neurobiological basis of spontaneous alternation. Neuroscience & Biobehavioral Reviews 26: 91-104.
36. Dudchenko PA (2004) An overview of the tasks used to test working memory in rodents. Neuroscience & Biobehavioral Reviews 28: 699-709.
37. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behavioural Brain Research 31: 47-59.
38. Dodart JC, Mathis C, Ungerer A (1997) Scopolamine-induced deficits in a two-trial object recognition task in mice. Neuroreport 8: 1173-1178. (Pubitemid 27198592)
39. Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, et al. (2013) Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging 34: 2699-2714.
40. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease. Arch Neurol 67: 961-964.
41. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
42. Lambert J-C, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
43. Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, et al. (2011) Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry.
44. Lambert J-C, Amouyel P (2011) Genetics of Alzheimer's disease: new evidences for an old hypothesis? Current Opinion in Genetics & Development 21: 295-301.
45. Fagni L, Worley PF, Ango F (2002) Homer as Both a Scaffold and Transduction Molecule. Sci STKE 2002: re8-.
46. Duncan RS, Hwang S-Y, Koulen P (2005) Effects of Vesl/Homer Proteins on Intracellular Signaling. Experimental Biology and Medicine 230: 527-535. (Pubitemid 41233151)
47. Shepherd JD, Bear MF (2011) New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci 14: 279-284.
48. Palop JJ, Mucke L (2010) Amyloid-[beta]-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13: 812-818.
49. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, et al. (2007) Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease. Neuron 55: 697-711. (Pubitemid 47321079)
50. Selenica M-L, Benner L, Housley SB, Manchec B, Lee DC, et al. (2014) Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition. Alzheimer's research & therapy 6: 12.
51. Teri L, Ferretti LE, Gibbons LE, Logsdon RG, McCurry SM, et al. (1999) Anxiety in Alzheimer's Disease: Prevalence and Comorbidity. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 54: M348-M352. (Pubitemid 129785356)
52. Badrakalimuthu VR, Tarbuck AF (2012) Anxiety: a hidden element in dementia. Advances in Psychiatric Treatment 18: 119-128.
53. Liu W, Miller BL, Kramer JH, Rankin K, Wyss-Coray C, et al. (2004) Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology 62: 742-748. (Pubitemid 38298950)
54. Hammond RS, Tull LE, Stackman RW (2004) On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiology of Learning and Memory 82: 26-34. (Pubitemid 38737427)
55. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H (2002) Hippocampal Damage and Exploratory Preferences in Rats: Memory for Objects, Places, and Contexts. Learning & Memory 9: 49-57. (Pubitemid 34507491)
56. Langen M, Kas MJH, Staal WG, van Engeland H, Durston S (2011) The neurobiology of repetitive behavior: Of mice.... Neuroscience & Biobehavioral Reviews 35: 345-355.
57. McKinney BC, Schneider JS, Schafer GL, Lowing JL, Mohan S, et al. (2008) Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter. Genes Brain Behav 7: 203-213. (Pubitemid 351342196)
58. Han HJ, Allen CC, Buchovecky CM, Yetman MJ, Born HA, et al. (2012) Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator. J Neurosci 32: 10574-10586.
59. Krakauer T, Buckley M (2003) Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines. Antimicrobial Agents and Chemotherapy 47: 3630-3633. (Pubitemid 37345735)
60. Milano S, Arcoleo F, D'Agostino P, Cillari E (1997) Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrobial Agents and Chemotherapy 41: 117-121. (Pubitemid 26428144)
61. Solomon A, Rosenblatt M, Li D-Q, Liu Z, Monroy D, et al. (2000) Doxycycline Inhibition of Interleukin-1 in the Corneal Epithelium. Investigative Ophthalmology & Visual Science 41: 2544-2557. (Pubitemid 30624381)
62. Yi C, Zhang Z, Wang W, Zug C, Schluesener H, et al. (2011) Doxycycline Attenuates Peripheral Inflammation in Rat Experimental Autoimmune Neuritis. Neurochemical Research 36: 1984-1990.
63. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, et al. (2009) STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: D412-416.